|| Print ||
ICSPP ~ for Empathic Human Sciences and Services
Peter R. Breggin, MD is no longer affiliated with the Center for the Study of Psychiatry, informally known as International Center for the Study of Psychiatry and Psychology, which he founded and led from 1972-2002, and Dr. Breggin will no longer be involved in its conferences.
Now Dr. Peter Breggin and his wife, Ginger Breggin are forming a new reform organization to carry forward this reform work by putting the focus back on the individual and not the diagnosis or the drug. We have dual purposes: 1. To carry forward and expand the 40 years of biopsychiatric reform that Dr. Breggin has so brilliantly spearheaded. And 2. To encourage and inspire humane and ethical social services and therapies that assist individuals and families toward better and more successful lives without the harmful effects of biopsychiatric interventions.
Join Dr. Peter Breggin, Ginger Breggin, and our growing list of Advisory Council members in continuing to strive to improve mental health care and inspire counselors, educators, psychiatrists, psychologists and psychotherapists everywhere. Our new reform organization is open to professionals and laypersons who are interested in better solutions to human emotional trauma and crisis. Our annual conferences are the highlight of our new Center for the Study of Empathic Therapy. We also offer an informative monthly e-newsletter and the opportunity to join together to bring about both reform and inspired new approaches to human emotional suffering.
Dr. Peter Breggin, has been informing the professions, media and the public about the potential dangers of drugs, electroshock, psychosurgery, involuntary treatment, and the biological theories of psychiatry for over four decades. Since 1964 Dr. Breggin has been publishing peer-reviewed articles and medical books in his subspecialty of clinical psychopharmacology. He is the author of dozens of scientific articles and nineteen professional books about psychiatric medication, the FDA and drug approval process, the evaluation of clinical trials, and standards of care in psychiatry and related fields. Dr. Breggin has brought about important reform accomplishments including stopping the resurgence of lobotomy in the early 1970s, alerting the public and the Food and Drug Administration about unexposed hazards of various psychiatric drugs resulting in drug label changes, and advocating for the protection of children, the elderly and other vulnerable persons from the abusive treatments of biopsychiatry.